Use access key #2 to skip to page content.
$17.02 -0.11 (-0.64%)
11/18/2008 4:00 PM

Matrixx Initiatives, Inc. (MTXX)

CAPS Rating:
*****

The Company develops, produces, markets and sells innovative, over-the-counter healthcare products.

View All Commentary (MTXX)

Recs

2

Avatar Madmykl (24.74) Submitted: 12/02/07 7:28 AM : Outperform Start Price: $16.15 MTXX Score: 46.62

Their Zicam product has good potential. As a physician I can read their research a little more deeply and the research appears okay... that is, there IS an effect with the product and the effect is substantial. Even though they talk about it being a homeoptathic remedy I suspect that the zinc itself may be contributing most or all of the effect of the product. Regardless, it appears to work.








Also, it appears that the recent lawsuits alleging smell and taste loss are baseless (however they have certainly made the stock price a bargain).





http://www.integratir.com/newsrelease.asp?news=2130981573&ticker=MTXX&lang=EN&title=null





This press release is of course from the company itself, however the major lawfirms that i have checked have stopped taking zicam cases which is a good sign.








The downside is that there ARE competitors out there, however none of the competition has done the research that these guys have. I do believe that matrixx has the edge here.

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links